References
Balik M, Rulisek J, Leden P, Zakharchenko M, Otahal M, et al. Concomitant use of beta-1 adrenergic blocker and norepinephrine in patients with septic shock. Wien Klin Wochenschr. 2012. doi:10.1007/s00508-012-0209-y.
Berk JL, Hagen JF, Beyer WH, Gerber MJ, Dochat GR. The treatment of endotoxin shock by a beta adrenergic blockade. Ann Surg. 1969;169:74–81.
Berk JL, Hagen JF, Maly G, Koo R. The treatment of shock with beta adrenergic blockade. Arch Surg. 1972;104:46–51.
Zambon M, Ceola M, Almeida-de-Castro R, Gullo A, Vincent JL. Implementation of surviving sepsis campaign guidelines for severe sepsis and septic shock: we could go faster. J Crit Care. 2008;23:455–60.
Kumar A, Roberts D, Wood KE, Light B, Parillo JE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96.
Kumar A, Anel R, Bunnell E, Habet K, Zanotti S, et al. Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular filling volume, cardiac performance, or the response to volume infusion in normal subjects. Crit Care Med. 2004;32:691–9.
Michard F, Alaya S, Zarka V, Bahloul M, Richard C Teboul JL, et al. Global end-diastolic volume as an indicator of cardiac preload in patients with septic shock. Chest. 2003;124:1900–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zante, B., Wirtz, S. Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock. A letter to the authors. Wien Klin Wochenschr 125, 54–55 (2013). https://doi.org/10.1007/s00508-012-0305-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-012-0305-z